Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > What is status of C-60 project?

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Feb 12, 2021 2:54pm

105 Views

Post# 32554866

RE:RE:RE:What is status of C-60 project?

Have never heard a peep about it since they revamped everything. But with VM one never knows when news will hit. Since that is newer technology that is being worked on, I do not expect the time frame to be precise. I value VM based on Barite and Iodine but if that stuff works out who knows just where the share price could end up. The potential for C60 is huge.

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price